Metoclopramide alone or combined with flurbiprofen in the treatment of orthostatic hypotension associated with diabetes mellitus
β Scribed by Beretta-Piccoli, C. ;Weidmann, P.
- Publisher
- Springer-Verlag
- Year
- 1982
- Tongue
- English
- Weight
- 255 KB
- Volume
- 60
- Category
- Article
- ISSN
- 1432-1440
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lines and multiple endocrinologic act
## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median followβup, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with earlyβstage breast cancer, anastrozole was superior to tamoxifen in terms of d